Quantcast
Channel: WN.com - Articles related to AbbVie Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients ...
Viewing all articles
Browse latest Browse all 986

Eliminating Barriers to Treatment for Patients with HCV Who Inject Drugs Presented: Sunday, November 15, 2015 - 3:45 pm - Moscone West Convention Center

$
0
0
SAN FRANCISCO, Nov. 15, 2015 /PRNewswire/ -- Injection drug use is a major risk factor for transmission of hepatitis C virus (HCV). In May 2015, the Centers for Disease Control reported that acute HCV infection in three Appalachian states rose by 364 percent among people under 30 years old, and 73 percent of those asked had used intravenous drugs. According to a presentation by Gregory Dore, MD, at the annual meeting of the American Association for the Study of Liver Diseases, very little data are available on interferon-free treatment of patients who have HCV and who use drugs. When asked why, Dr. Dore replied, "There has been concern that people who use illicit drugs will not be...

Viewing all articles
Browse latest Browse all 986

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>